SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- January 26, 2007 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will host an Investor R&D Day on February 5, 2007 in New York City from noon to 4:00 pm ET to provide a comprehensive review of preclinical and clinical development programs. The presentations will cover all of Theravance’s full discovery and development programs, except Beyond Advair, with a focus on Theravance’s approach to discovering, developing, and commercializing medicines.
